Bio-Connect

CD80 antibody [2D10.4]

GTX01487
GeneTex
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoCytoChemistry, Other Application
Product group Antibodies
TargetCD80
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CD80 antibody [2D10.4]
  • Delivery Days Customer
    9
  • Application Supplier Note
    *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, ImmunoFluorescence, ImmunoCytoChemistry, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    2D10.4
  • Concentration
    0.5 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID941
  • Target name
    CD80
  • Target description
    CD80 molecule
  • Target synonyms
    B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7, T-lymphocyte activation antigen CD80, B-lymphocyte activation antigen B7, CD80 antigen (CD28 antigen ligand 1, B7-1 antigen), CTLA-4 counter-receptor B7.1, activation B7-1 antigen, costimulatory factor CD80, costimulatory molecule variant IgV-CD80
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP33681
  • Protein Name
    T-lymphocyte activation antigen CD80
  • Scientific Description
    The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011]
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Bai J, Adriani G, Dang TM, et al. Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions. Oncotarget. 2015,6(28):25295-307. doi: 10.18632/oncotarget.4716
    Read this paper
  • Kapp K, Kleuss C, Schroff M, et al. Genuine Immunomodulation With dSLIM. Mol Ther Nucleic Acids. 2014,3(6):e170. doi: 10.1038/mtna.2014.28
    Read this paper
  • Bashuda H, Kimikawa M, Seino K, et al. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Invest. 2005,115(7):1896-902.
    Read this paper